Follow
Adil Doganay Duru
Adil Doganay Duru
Assistant Profesor at Nova Southeastern University
Verified email at nova.edu
Title
Cited by
Cited by
Year
Natural killer cell-based therapies targeting cancer: possible strategies to gain and sustain anti-tumor activity
CIM Dahlberg, D Sarhan, M Chrobok, AD Duru, E Alici
Frontiers in immunology 6, 605, 2015
1992015
Triticum durum metallothionein: isolation of the gene and structural characterization of the protein using solution scattering and molecular modeling
K Bilecen, UH Ozturk, AD Duru, T Sutlu, MV Petoukhov, DI Svergun, ...
Journal of Biological Chemistry 280 (14), 13701-13711, 2005
772005
The use of novel drugs can effectively improve response, delay relapse and enhance overall survival in multiple myeloma patients with renal impairment
K Uttervall, AD Duru, J Lund, J Liwing, G Gahrton, E Holmberg, J Aschan, ...
PLoS One 9 (7), e101819, 2014
642014
Natural killer cell tolerance persists despite significant reduction of self MHC class I on normal target cells in mice
P Brodin, T Lakshmikanth, R Mehr, MH Johansson, AD Duru, A Achour, ...
PloS one 5 (10), e13174, 2010
292010
Successive crystal structure snapshots suggest the basis for MHC class I peptide loading and editing by tapasin
I Hafstrand, EC Sayitoglu, A Apavaloaei, BJ Josey, R Sun, X Han, ...
Proceedings of the National Academy of Sciences 116 (11), 5055-5060, 2019
272019
Boosting natural killer cell-mediated targeting of sarcoma through DNAM-1 and NKG2D
EC Sayitoglu, AM Georgoudaki, M Chrobok, D Ozkazanc, BJ Josey, M Arif, ...
Frontiers in immunology 11, 40, 2020
262020
Engineering antigen‐specific NK cell lines against the melanoma‐associated antigen tyrosinase via TCR gene transfer
A Parlar, EC Sayitoglu, D Ozkazanc, AM Georgoudaki, C Pamukcu, ...
European journal of immunology 49 (8), 1278-1290, 2019
212019
Analysis of the Wnt/B-catenin/TCF4 pathway using SAGE, genome-wide microarray and promoter analysis: Identification of BRI3 and HSF2 as novel targets
E Kavak, A Najafov, N Ozturk, T Seker, K Cavusoglu, T Aslan, AD Duru, ...
Cellular signalling 22 (10), 1523-1535, 2010
212010
Re-challenging with anti-CD38 monotherapy in triple-refractory multiple myeloma patients is a feasible and safe approach.
E Alici, M Chrobok, J Lund, T Ahmadi, I Khan, AD Duru, H Nahi
British journal of haematology 174 (3), 473-477, 2015
182015
Inflammation-associated nitrotyrosination affects TCR recognition through reduced stability and alteration of the molecular surface of the MHC complex
C Madhurantakam, AD Duru, T Sandalova, JR Webb, A Achour
PLoS One 7 (3), e32805, 2012
162012
Functional assessment for clinical use of serum-free adapted NK-92 cells
M Chrobok, CIM Dahlberg, EC Sayitoglu, V Beljanski, H Nahi, M Gilljam, ...
Cancers 11 (1), 69, 2019
142019
The MHC class I cancer-associated neoepitope Trh4 linked with impaired peptide processing induces a unique noncanonical TCR conformer
I Hafstrand, EM Doorduijn, AD Duru, J Buratto, CC Oliveira, T Sandalova, ...
The Journal of Immunology 196 (5), 2327-2334, 2016
132016
Autologous peripheral blood mononuclear cells as treatment in refractory acute respiratory distress syndrome
P Jungebluth, B Holzgraefe, ML Lim, AD Duru, V Lundin, N Heldring, ...
Respiration 90 (6), 481-492, 2015
132015
Lipid-based transfection reagents exhibit cryo-induced increase in transfection efficiency
H Sork, JZ Nordin, JJ Turunen, OPB Wiklander, B Bestas, EM Zaghloul, ...
Molecular Therapy-Nucleic Acids 5, e290, 2016
112016
Deletion of chromosomal region 8p21 confers resistance to bortezomib and is associated with upregulated decoy TRAIL receptor expression in patients with multiple myeloma
AD Duru, T Sutlu, A Wallblom, K Uttervall, J Lund, B Stellan, G Gahrton, ...
PloS one 10 (9), e0138248, 2015
112015
Unexpected T‐cell recognition of an altered peptide ligand is driven by reversed thermodynamics
EB Allerbring, AD Duru, H Uchtenhagen, C Madhurantakam, MB Tomek, ...
European journal of immunology 42 (11), 2990-3000, 2012
112012
The immunogenicity of a proline-substituted altered peptide ligand toward the cancer-associated TEIPP neoepitope Trh4 is unrelated to complex stability
I Hafstrand, EM Doorduijn, R Sun, A Talyzina, M Sluijter, S Pellegrino, ...
The Journal of Immunology 200 (8), 2860-2868, 2018
92018
Characterization of zika virus infection of human fetal cardiac mesenchymal stromal cells
F Rossi, B Josey, EC Sayitoglu, R Potens, T Sultu, AD Duru, V Beljanski
PloS one 15 (9), e0239238, 2020
52020
Tuning antiviral CD8 T-cell response via proline-altered peptide ligand vaccination
AD Duru, R Sun, EB Allerbring, J Chadderton, N Kadri, X Han, K Peqini, ...
PLoS pathogens 16 (5), e1008244, 2020
52020
Crystal structures of H-2Db in complex with the LCMV-derived peptides GP92 and GP392 explain pleiotropic effects of glycosylation on antigen presentation and …
I Hafstrand, D Badia-Martinez, BJ Josey, M Norström, J Buratto, ...
Plos one 12 (12), e0189584, 2017
42017
The system can't perform the operation now. Try again later.
Articles 1–20